Previous job - National Sales Manager

National Sales Manager

Managing a team of experienced Key Account Managers focussed on contract pricing and PCT negotiation.

Reporting into Head of Biopharmaceuticals.

Products:
Products: Filgrastim: It is used for treating neutropenia, a common side effect of chemotherapy.

Epo-Alpha : prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. ...

Omnitrope (somatropin) is a form of human growth hormone used to treat adults and children with growth failure.

Biosimilars – a major future market
By 2010, it is estimated that more than 50% of newly approved medicines will be biopharmaceuticals. The period beginning in 2010 will also see an increasing number of major biotechnology-based medicines coming off patent and facing generic competition.

Biosimilars, or follow-on proteins, are new versions of existing biopharmaceuticals whose patents have expired. They are produced using the same core genetic material and are approved on the basis that they are equal to the reference product in terms of both safety and efficacy. Biosimilars are large, complex molecules produced by living organisms, which are sensitive to manufacturing changes; generics are small molecules, produced by chemical synthesis, which are usually very stable. Biosimilars is an official term used by the European medical authorities; the US terminology is follow-on protein products (FOPPs).

At Sandoz, we are playing a pioneer role in the development of this exciting new field, which offers major savings to patients and healthcare systems and promises to become a major future market for companies like Sandoz.

With decades of experience in biotechnology, a global development and production network and an unrivalled reputation for quality, Sandoz is ideally placed to capture the biosimilars opportunity. Indeed, we are already at the forefront of bringing affordable high-quality biosimilars to patients once patents expire. Following the precedent-setting launch of human growth hormone Omnitrope® in both the EU and the US, we have now also marketed the first truly complex biosimilar (anemia medicine epoetin alfa) in the EU.

Package d'emploi

Competetive basic salary and full benefits package:

inc car allowance aprox £500 per month
15% bonus


Personne Profil

Seeking an experienced sales manager, preference for someone with experience of managing senior key acocunt teams. HDM or equivalent.

Experience in the following disease areas will be an advantage.

Oncology
Nephrology
Renal
Haemotology
Endocrinology


Processus d'entrevue

2-3 stage TBC

See more jobs from Sandoz
Sandoz
* Guide des Salaires
£65,000
National
Job Ref: 37521

Pourquoi Zenopa?

  • Relations de longue date

    Zenopa développer des relations de travail solides avec nos clients, ce qui signifie que nous comprenons leur entreprise et les valeurs culturelles.

  • Qualité Contrôlée

    Zenopa exploiter un Système de Management Qualité (SMQ) et nous vérifié pour assurer une excellente qualité de service.

  • Interview Preparation

    Nous vous préparons bien pour tous les entretiens et obtient, une rétroaction constructive plein après que vous avez rencontré le client.

  • Support & Conseils

    Zenopa fournir un service constant. Il y aura toujours quelqu'un à la fin du téléphone pour répondre à vos questions.

  • Recrutement d'intégrité

    Nous serons toujours vous fournir des conseils honnêtes et professionnelle et pleinement comprendre les besoins de votre carrière.

  • Hautement Recommandé

    Nos normes de service à la clientèle sont extrêmement élevés. Nous sommes fortement recommandé par 96% des clients et 98% des candidats.